171 related articles for article (PubMed ID: 25556956)
61. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
Ji L; Dong C; Fan R; Qi S
Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
[TBL] [Abstract][Full Text] [Related]
62. Deoxynivalenol-mimic nanobody isolated from a naïve phage display nanobody library and its application in immunoassay.
Qiu YL; He QH; Xu Y; Bhunia AK; Tu Z; Chen B; Liu YY
Anal Chim Acta; 2015 Aug; 887():201-208. PubMed ID: 26320803
[TBL] [Abstract][Full Text] [Related]
63. A Two-Step Approach for the Design and Generation of Nanobodies.
Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
[TBL] [Abstract][Full Text] [Related]
64. Development and production of nanobodies specifically against green fluorescence protein.
Fang Z; Cao D; Qiu J
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250
[TBL] [Abstract][Full Text] [Related]
65. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
[TBL] [Abstract][Full Text] [Related]
66. In vitro affinity maturation to improve the efficacy of a hypoxia-inducible factor 1α single-domain intrabody.
Hu M; Kang G; Cheng X; Wang J; Li R; Bai Z; Yang D; Huang H
Biochem Biophys Res Commun; 2020 Sep; 529(4):936-942. PubMed ID: 32819602
[TBL] [Abstract][Full Text] [Related]
67. Characterization and Selection of 3-(1-Naphthoyl)-Indole Derivative-Specific Alpaca VHH Antibodies Using a Phage Display Library.
Nakayama H; Murakami A; Yoshida M; Muraoka J; Wakai J; Kenjyou N; Ito Y
Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):231-4. PubMed ID: 27556911
[TBL] [Abstract][Full Text] [Related]
68. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
Ferrari D; Garrapa V; Locatelli M; Bolchi A
Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
[TBL] [Abstract][Full Text] [Related]
69. Multiplexed fluid array screening of phage displayed anti-ricin single domain antibodies for rapid assessment of specificity.
Anderson GP; Matney R; Liu JL; Hayhurst A; Goldman ER
Biotechniques; 2007 Dec; 43(6):806-11. PubMed ID: 18251258
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of type VI secretion by an anti-TssM llama nanobody.
Nguyen VS; Logger L; Spinelli S; Desmyter A; Le TT; Kellenberger C; Douzi B; Durand E; Roussel A; Cascales E; Cambillau C
PLoS One; 2015; 10(3):e0122187. PubMed ID: 25811612
[TBL] [Abstract][Full Text] [Related]
71. Comparison of Three Antihapten VHH Selection Strategies for the Development of Highly Sensitive Immunoassays for Microcystins.
Pírez-Schirmer M; Rossotti M; Badagian N; Leizagoyen C; Brena BM; González-Sapienza G
Anal Chem; 2017 Jun; 89(12):6800-6806. PubMed ID: 28494149
[TBL] [Abstract][Full Text] [Related]
72. Surface display of a single-domain antibody library on Gram-positive bacteria.
Fleetwood F; Devoogdt N; Pellis M; Wernery U; Muyldermans S; Ståhl S; Löfblom J
Cell Mol Life Sci; 2013 Mar; 70(6):1081-93. PubMed ID: 23064703
[TBL] [Abstract][Full Text] [Related]
73. A Comparison Between Cell, Protein and Peptide-Based Approaches for Selection of Nanobodies Against CD44 from a Synthetic Library.
Kavousipour S; Mokarram P; Gargari SLM; Mostafavi-Pour Z; Barazesh M; Ramezani A; Ashktorab H; Mohammadi S; Ghavami S
Protein Pept Lett; 2018; 25(6):580-588. PubMed ID: 29848261
[TBL] [Abstract][Full Text] [Related]
74. Native llama Nanobody Library Panning Performed by Phage and Yeast Display Provides Binders Suitable for C-Reactive Protein Detection.
Oloketuyi S; Bernedo R; Christmann A; Borkowska J; Cazzaniga G; Schuchmann HW; Niedziółka-Jönsson J; Szot-Karpińska K; Kolmar H; de Marco A
Biosensors (Basel); 2021 Dec; 11(12):. PubMed ID: 34940253
[TBL] [Abstract][Full Text] [Related]
75. Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases.
Guan SY; Leng RX; Tao JH; Li XP; Ye DQ; Olsen N; Zheng SG; Pan HF
Expert Opin Ther Targets; 2017 Jul; 21(7):715-723. PubMed ID: 28553732
[TBL] [Abstract][Full Text] [Related]
76. A novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma.
Wu W; Li S; Zhang W; Sun J; Ren G; Dong Q
Int J Mol Sci; 2014 May; 15(6):9481-96. PubMed ID: 24879522
[TBL] [Abstract][Full Text] [Related]
77. [Screening, expression and characterization of anti-human CD20 nanobodies].
Li Y; Li G; Wang H; Jiang D; Chu Y; Zhang A; Xu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):67-72. PubMed ID: 33441230
[TBL] [Abstract][Full Text] [Related]
78. Recent advances in the selection and identification of antigen-specific nanobodies.
Liu W; Song H; Chen Q; Yu J; Xian M; Nian R; Feng D
Mol Immunol; 2018 Apr; 96():37-47. PubMed ID: 29477934
[TBL] [Abstract][Full Text] [Related]
79. Nanobody-based binding assay for the discovery of potent inhibitors of CFTR inhibitory factor (Cif).
Vasylieva N; Kitamura S; Dong J; Barnych B; Hvorecny KL; Madden DR; Gee SJ; Wolan DW; Morisseau C; Hammock BD
Anal Chim Acta; 2019 May; 1057():106-113. PubMed ID: 30832908
[TBL] [Abstract][Full Text] [Related]
80. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
